SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke

People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds (medicalxpress); SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke (acc)

Image: medicalxpress